Alzheimer's Association Session

Explore Cutting-edge Developments in Brain Health, Diagnosis, and Treatments

Join us Wednesday March 11th from 8:30 am – 11:00 am 

Learn how lifestyle interventions can reduce the risk of cognitive impairment, how blood-based biomarkers are enabling earlier, more accessible Alzheimer’s diagnosis and advancements in treatments.  The second half of this session will provide a comprehensive overview of rapidly moving innovations within dementia care speciality models including both Medicare and Medicare Advantage funded approaches.  The impressive early clinical and cost savings outcomes and how LTCI specifically might take advantage in the short-to-mid-term.  Discussions will include an overview of the Dementia Care Navigation Service, powered by Rippl and the Alzheimer’s Association, which has shown promising results including a 30% drop in emergency department visits and a 15% reduction in hospital admissions through personalized, proactive support aligned with Center for Medicare and Medicaid’s GUIDE Model.

Moderator: Denise Liston

Moderator: Denise Liston

Senior Vice President, illumifin

Speaker: Christopher Weber, PhD

Speaker: Christopher Weber, PhD

Senior Director, Global Science Initiatives, Alzheimer’s Association

Speaker: Kris Engskov

Speaker: Kris Engskov

Co-Founder & CEO, Rippl

Organization Overview
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. Our Vision is A world without Alzheimer’s and all other dementia. Our Mission is The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. The Colorado Chapter is part of a national chapter network advancing this work across the country. 

Follow by Email
Twitter
LinkedIn